Chinese consensus for the anti-seizure medications polytherapy
Epilepsy is one of the common chronic diseases of the central nervous system,and the therapy of anti-seizure medications(ASMs)is the most important therapy method for epilepsy.If the treatment goal of seizure-free is not reached after the initial monotherapy,another ASMs should be selected as substitution or combination therapy.At present,there are more than 20 kinds of ASMs licensed for use in China.A series of problems,such as when to start the ASMs polytherapy,the choice of polytherapy schedules,and the precautions for polytherapy,often cause problems for clinicians to make decisions.Therefore,experts from the Chinese Society of Electroencephalography and Epilepsy discussed and wrote"Chinese consensus for the anti-seizure medications polytherapy",aimed to provide clinicians with practical,standardized treatment for the patients with ASMs polytherapy in China.